ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Aclara Biosciences, (MM)

Aclara Biosciences, (MM) (ACLA)

0.00
0.00
( 0.00% )

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

ACLA Últimas noticias

ViroLogic and ACLARA Announce Stockholder Approval of Merger

ViroLogic and ACLARA Announce Stockholder Approval of Merger Merger Expected to Be Completed By End of Day SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW, Calif., Dec. 10 /PRNewswire-FirstCall/...

Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers

Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers REYKJAVIK, Iceland, Dec. 2 /PRNewswire/ -- Iceland Genomics Corporation (IGC) announced today that they have entered...

ACLARA Announces Third Quarter 2004 Financial Results

ACLARA Announces Third Quarter 2004 Financial Results MOUNTAIN VIEW, Calif. Nov. 9 /PRNewswire-FirstCall/ -- ACLARA BioSciences (NASDAQ:ACLA), today reported financial results for the three and...

ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger

ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger New Date Set for Stockholder Meetings SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW, Calif., Nov. 8...

Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment

Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment MOUNTAIN VIEW, Calif., Nov. 4 /PRNewswire-FirstCall/ -- ACLARA...

Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board

Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board Another Distinguished Oncologist Highlights Company's Advancements in Protein-Based Diagnostics MOUNTAIN VIEW...

ViroLogic and ACLARA BioSciences Revise Merger Terms

ViroLogic and ACLARA BioSciences Revise Merger Terms ViroLogic Provides Preliminary Third Quarter Revenue Estimate SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW, Calif., Oct. 19...

ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies

ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- ACLARA...

ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosi

ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosis MOUNTAIN VIEW, Calif. and GENEVA, Sept. 30...

ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger

ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger Date Set for Stockholder Meetings SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW, Calif., Sept. 28 /PRNewswire-FirstCall/...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACLA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aclara Biosciences?
El precio actual de las acciones de Aclara Biosciences es US$ 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aclara Biosciences?
Aclara Biosciences ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NXUNXU Inc
US$ 1.6989
(597.99%)
501.66M
WATTEnergous Corporation
US$ 1.45
(252.63%)
171.38M
INTZIntrusion Inc
US$ 5.12
(137.04%)
120.09M
AERTAeries Technology Inc
US$ 2.07
(136.06%)
3.86M
SMXSMX Security Matters Public Company
US$ 0.7701
(117.79%)
255.2M
ABPAbpro Holdings Inc
US$ 2.12
(-52.78%)
1.59M
TRAWTraws Pharma Inc
US$ 8.07
(-39.87%)
958.15k
LITMSnow Lake Resources Ltd
US$ 1.16
(-27.50%)
47.54M
DOMHDominari Holdings Inc
US$ 0.8391
(-27.03%)
154.06k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 67.89
(-23.26%)
13.31k
NXUNXU Inc
US$ 1.6989
(597.99%)
505.03M
VINCVincerx Inc
US$ 0.344
(77.32%)
313.84M
SMXSMX Security Matters Public Company
US$ 0.7701
(117.79%)
255.83M
XTIAXTI Aerospace Inc
US$ 0.03995
(1.14%)
206.47M
WATTEnergous Corporation
US$ 1.45
(252.63%)
172.12M
fung_derf fung_derf 1 minuto hace
Other AI bots.....or a few special technicians......so only 92% of the work force ineffective.
AI
delerious1 delerious1 1 minuto hace
What's the supersack sitting on at the back....is that where it is emptied into the Mill??
NBRI
SniffinPennies SniffinPennies 2 minutos hace
End of Year tax sale almost over. Sellers now haven't been in the OTC very long to know the New Year trading pattern
CGAC
stocktowatch stocktowatch 2 minutos hace
$IVDN today issues the following letter to shareholders from new CEO Joseph A. Riccelli. This letter covers the Company's fiscal third quarter financial results and forward-looking projections, as well as a discussion of significant events in 2024 and plans for the future.


IVDN
amelia43 amelia43 2 minutos hace
Are we scooping up cheapies still?
FNMA
sab63090 sab63090 2 minutos hace
Hoskuld:

Yes, thanks!

I think your experience is extremely valuable and the recent price push UP signals that things have indeed changed!
AVXL
tw0122 tw0122 2 minutos hace
.73
MGOL
RIGATONI RIGATONI 3 minutos hace
.41 nice volume ~Rig
DimesForShares DimesForShares 3 minutos hace
I found myself in almost complete agreement with this post.  I wouldn't call 2024 'awesome' but I will go with 'very good.'  During this past year, KBLB learned what was needed to move silk from the laboratory to commercial production.  Thompson still has the challenge of sustaining production at th
KBLB
luckydude777 luckydude777 3 minutos hace
One thing to observe about ASST is that the company knows how to get the share price up above $1.00 for over 10 days to keep it from receiving one of those irritating Nasdaq price compliant notices.
ASST
LowFloatLopes LowFloatLopes 3 minutos hace
This will be a fun ride up in 2025 if crypto has a good year 
CYFRF
Involuntary-Recluse Involuntary-Recluse 3 minutos hace
My example of fraud is something like Bre-X, where you walk by the tailings, drop your gold ring on top, and issue PR's stating visible gold, hence the stock price hitting $200.

Cases like ASKH, are simple incompetence/negligence and stupidity as no one makes any $$ form this, with th
ASKH
McTank630 McTank630 3 minutos hace
Dear management,

Would love to hear a word from you! No PR announcement, just a real and raw interaction / update live on camera!

Kind regards,
Patient supporters
NWBO
powerbattles powerbattles 3 minutos hace
Share Structure
Market Cap Market Cap
642,022 - 12/27/2024
Authorized Shares
4,000,000,000 - 12/13/2024
Outstanding Shares 1,167,313,456 - 12/13/2024
Restricted 500,847,878 - 12/13/2024
Unrestricted 666,465,578 - 12/13/2024
Held at DTC 534,815,
AFFU
tw0122 tw0122 3 minutos hace
Little action

MGOL
Slim6 Slim6 4 minutos hace
QUBT is going to lose another $300 million during the next year. This is getting worse. The tangible book value has already gone into negative. Dilution continues as shareholders are duped further. Beware. The company is teetering on bankruptcy.
QUBT
Shareing is winning Shareing is winning 4 minutos hace
GET YOUR BUY;S IN AT .021 OR BE LEFT BEHIND LITTERALLY!
TORVF
RIGATONI RIGATONI 4 minutos hace
.989 new high ~Rig
LowFloatLopes LowFloatLopes 4 minutos hace
Finally back on the run .. it's been stuck in a sideways pattern last few weeks 
CYFRF
tw0122 tw0122 4 minutos hace
BLBX might be it for now $4.10
BLBX
maddyandboomer maddyandboomer 5 minutos hace
The ask is 35 times the size of bid at trip 8....oh sorry - that is a bad thing
AXXA
Whalatane Whalatane 5 minutos hace
Health providers typically renegotiate drug supply contracts annually, though practices can vary. Here's a breakdown of common renegotiation frequencies:
Annual Renegotiation
Most healthcare organizations and physicians review and renegotiate their major payer contracts at least once a
UNCY
Golden Cross Golden Cross 5 minutos hace
$ILLR Conor McGregor Wants To Convert #BKFC Into A Global Phenomenon. BKFC President David Feldman says
Conor McGregor has helped BKFC grow massively.
https://www.essentiallysports.com/ufc-mma-news-bkfc-president-says-conor-mcgregor-has-ten-folded-bkfc-metrics/

@triller
ILLR
Monksdream Monksdream 5 minutos hace
WATT, quite a gap to fill
https://investorshub.advfn.com/uimage/uploads/2024/12/30/arbaoIMG_4343.gif

Energous Corp. engages in the development of wireless charging technology. It focuses on the product, WattUp, a wireless power technology consisting of proprietary semiconductor
i_like_bb_stock i_like_bb_stock 5 minutos hace
TNON volume increasing catalyst upcoming "Successfully completed initial clinical cases (alpha) of Tenon's new Catamaran SE SI Joint Fusion System.

National introduction of Catamaran SE is expected in early 2025."
TNON